BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
66 results:

  • 1. Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.
    Judd S; Revon-Riviere G; Grover SA; Deyell RJ; Vanan MI; Lewis VA; Pecheux L; Zorzi AP; Goudie C; Santiago R; Tran TH; Abbott LS; Brossard J; Moorehead P; Alvi S; Portwine C; Denburg A; Whitlock JA; Cohen-Gogo S; Morgenstern DA
    Cancer Med; 2024 Feb; 13(3):e7033. PubMed ID: 38400668
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Systematic review of mortality and survival rates for APDS.
    Hanson J; Bonnen PE
    Clin Exp Med; 2024 Jan; 24(1):17. PubMed ID: 38280023
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
    Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
    Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
    Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
    Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
    Karolová J; Kazantsev D; Svatoň M; Tušková L; Forsterová K; Maláriková D; Benešová K; Heizer T; Dolníková A; Klánová M; Winkovska L; Svobodová K; Hojný J; Krkavcová E; Froňková E; Zemanová Z; Trněný M; Klener P
    Am J Hematol; 2023 Oct; 98(10):1627-1636. PubMed ID: 37605345
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma.
    Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Hegazy M; Elballal MS; Mohammed OA; El-Husseiny HM; Midan HM; El-Dakroury WA; Zewail MB; Abdel Mageed SS; Doghish AS
    Pathol Res Pract; 2023 Aug; 248():154704. PubMed ID: 37499518
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
    Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
    Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia.
    Sarno J; Domizi P; Liu Y; Merchant M; Pedersen CB; Jedoui D; Jager A; Nolan GP; Gaipa G; Bendall SC; Bava FA; Davis KL
    Nat Commun; 2023 May; 14(1):2935. PubMed ID: 37217509
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review.
    Shadman M
    JAMA; 2023 Mar; 329(11):918-932. PubMed ID: 36943212
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genes associated with diagnosis and prognosis of Burkitt lymphoma.
    Doughan A; Salifu SP
    IET Syst Biol; 2022 Dec; 16(6):220-229. PubMed ID: 36354023
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
    Rosenberg MW; Savage SL; Eide CA; Reister Schultz A; Cook RJ; Press RD; Rempfer C; Eickelberg G; Wilmot B; McWeeney SK; Tyner JW; Druker BJ; Tognon CE
    Cold Spring Harb Mol Case Stud; 2022 Oct; 8(6):. PubMed ID: 36307214
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry.
    Gong Y; Zhou L; Ding L; Zhao J; Wang Z; Ren G; Zhang J; Mao Z; Zhou R
    Medicine (Baltimore); 2022 Jun; 101(24):e29312. PubMed ID: 35713434
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.
    Sbirkov Y; Vergov B; Mehterov N; Sarafian V
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563051
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
    Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
    Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System lymphoma from Glioma.
    Si PP; Zhou XH; Qu ZZ
    J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The utility of cerebrospinal fluid-derived cell-free DNA in molecular diagnostics for the
    Chen WL; Pao E; Owens J; Glass I; Pritchard C; Shirts BH; Lockwood C; Mirzaa GM
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483878
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Follicular lymphoma: a Focus on Current and Emerging Therapies.
    Cahill KE; Smith SM
    Oncology (Williston Park); 2022 Feb; 36(2):97-106. PubMed ID: 35180337
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Resistance of B-Cell lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
    Laurent C; Syrykh C; Hamon M; Adélaïde J; Guille A; Escudié F; Jalowicki G; Fina F; Bardet A; Mescam L; Molina TJ; Dartigues P; Parrens M; Sujobert P; Besson C; Birnbaum D; Xerri L
    Am J Surg Pathol; 2022 Jun; 46(6):742-753. PubMed ID: 34799485
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Early Progressing Follicular lymphoma.
    Wallace D; Casulo C
    Curr Oncol Rep; 2021 Nov; 23(12):149. PubMed ID: 34797453
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.